Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Combination Therapy of Rucaparib and Irinotecan in Cancers With Mutations in DNA Repair

NCT03318445 is registered in ClinicalTrials.gov with Pamela Munster as lead sponsor.

NCT NCT03318445
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03318445 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Combination Therapy of Rucaparib and Irinotecan in Cancers With Mutations in DNA Repair
Lead sponsor
Pamela Munster
Phase
Phase 1
Overall status
Completed
Start date
January 12, 2018
Completion date
March 1, 2021
Enrollment
22 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

solid tumor, unspecified, adult